Seed VC · Cheltenham, United Kingdom
Biovance Capital invests in disruptive, early-stage biopharma companies across Europe, supporting the development of transformational therapies across all modalities and therapeutic areas, working closely with portfolio companies to bring novel medical treatments to patients in need.
Business models
biotech_therapeutics
Customer segments
Researchers, Patients
Geography
Europe, Portugal
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
Biovance Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Biovance Capital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Seed VC
Advice Capital
biotech, global equities
Seed VC
AgFunder
agrifoodtech, AI, biotech
Seed VC
Aloe Private Equity
deeptech, biotech
Seed VC
AMR Action Fund
biotech, antimicrobial resistance, antibiotics
Angel
Angel Academe - increasing female investment
cleantech, healthtech, fintech
Seed VC
Auxxo Female Catalyst Fund
climate tech, construction tech, biotech
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Biovance Capital is one of them, and we'll tell you exactly where they sit in your top 100.